ID: ALA2414451

Max Phase: Preclinical

Molecular Formula: C11H12BrN3O

Molecular Weight: 282.14

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Brc1cccc(OCCCn2cncn2)c1

Standard InChI:  InChI=1S/C11H12BrN3O/c12-10-3-1-4-11(7-10)16-6-2-5-15-9-13-8-14-15/h1,3-4,7-9H,2,5-6H2

Standard InChI Key:  CRVBTEVUJYOWCG-UHFFFAOYSA-N

Associated Targets(non-human)

Hmox2 Heme oxygenase 2 (264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hmox1 Heme oxygenase 1 (289 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 282.14Molecular Weight (Monoisotopic): 281.0164AlogP: 2.51#Rotatable Bonds: 5
Polar Surface Area: 39.94Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.07CX LogP: 2.19CX LogD: 2.19
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.79Np Likeness Score: -2.24

References

1. Salerno L, Pittalà V, Romeo G, Modica MN, Siracusa MA, Di Giacomo C, Acquaviva R, Barbagallo I, Tibullo D, Sorrenti V..  (2013)  Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.,  21  (17): [PMID:23867390] [10.1016/j.bmc.2013.06.040]
2. Salerno L, Pittalà V, Romeo G, Modica MN, Marrazzo A, Siracusa MA, Sorrenti V, Di Giacomo C, Vanella L, Parayath NN, Greish K..  (2015)  Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.,  96  [PMID:25874340] [10.1016/j.ejmech.2015.04.003]

Source